Skip to main content

Day: February 3, 2022

International kitchen provider Kvik selects Agillic and Tealium to optimise its customer journey

Agillic welcomes KvikKvik joins Agillic to facilitate personalised communication to millionsPress release, Copenhagen, 3 February 2022 Danish kitchen provider Kvik is cooking up a new marketing plan to boost expansion across its thirteen regions of operation. To support this plan, Kvik joins Agillic to facilitate personalised communication and further enhance its customer journey. Danish company Kvik offers kitchens, bathrooms and wardrobes in minimalist Danish design, and at a minimal price. Though it already has stores in thirteen countries, Kvik is growing rapidly, with plans to open over 100 more shops by 2024. To turn up the volume on these initiatives, Kvik has chosen Agillic with Gold solution partner NexusOne to deliver the solution and support the platform implementation and utilisation. Kvik operates with a multitude...

Continue reading

Herbal Medicine Market to Surpass USD 430 Billion by 2028; Demand for Natural & Organic Products to Support Growth: Fortune Business Insights™

Companies covered in herbal medicine market are KPC Products Inc. (California, U.S.), NEXIRA (Normandy, France), HISHIMO PHARMACEUTICALS (Rajasthan, India), Schaper & Brümmer GmbH & Co. KG (Salzgitter, Germany), Sydler Group of Companies (India), 21ST Century HealthCare, Inc. (Arizona, U.S.), Zoic Pharmaceuticals (Punjab, India), Herbally Yours, Inc. (Arizona, U.S.), Pharma Nord B.V. (Vejle, Denmark), NATURLAND (Gräfelfing, Germany) and more players profiled Pune, India, Feb. 03, 2022 (GLOBE NEWSWIRE) — The global Herbal Medicine Market size reached USD 185.86 billion in 2020. The market valuation is set to rise from USD 203.03 billion in 2021 to USD 430.05 billion in 2028 at a CAGR of 11.32% during the projected period. The market growth and rising product demand are attributable to increasing health consciousness among...

Continue reading

Tarkett launches 2030 Climate Roadmap / Independent organization Science Based Targets (SBTi) begins today evaluation of the company’s greenhouse gas reduction targets

Tarkett launches 2030 Climate Roadmap Independent organization Science Based Targets (SBTi) begins today evaluation of the company’s greenhouse gas reduction targets PARIS, FRANCE, February 3, 2022 – Tarkett, a worldwide leader in innovative and sustainable flooring and sports surface solutions, announced today its new Climate Roadmap for 2030, in full alignment with the Paris Climate Agreement objective to limit global warming to 1.5°C. The company will deliver a 30% reduction in greenhouse gas emissions across its entire value chain by 20301. Today, the independent organization Science Based Targets (SBTi) has started the evaluation and approval of Tarkett’s greenhouse gas reduction targets.2 Tarkett’s Climate Roadmap for 2030 covers reductions in greenhouse gas emissions from its own activities (Scope 1) and its purchased energy...

Continue reading

Proactive news headlines including Star Minerals, AdAlta Ltd, CardieX Ltd and Creso Pharma

Sydney, Feb. 03, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Star Minerals Ltd (ASX:SMS) was admitted to the official list of the ASX in October 2021 with two projects in Western Australia – Tumblegum South, 40 kilometres south of Meekatharra and the West Bryah Project, 120 kilometres northwest of Meekatharra. Click here AdAlta Ltd (ASX:1AD) has completed a $1.25 million entitlement offer, bringing total funds raised to $5 million after the completion of a share placement in December 2021. Click here CardieX Ltd (ASX:CDX)’s most recent quarter saw strong shareholder take up of its options offer, with a 93% conversion rate raising A$7.6 million in November. Click here Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF)...

Continue reading

Publicis Groupe : Full Year 2021 Results/ Résultats annuels 2021

Full Year 2021 Results–Strong Q4 and record year on all KPIs February 3, 2022Full year 2021 organic growth at +10% with Q4 at +9.3% ahead of expectations Epsilon and Publicis Sapient accretive to overall 2021 performance at +12.8% and +13.8% respectively Exceeding 2019 levels with +3% organic growth in 2021, accelerating to +5% in second half N°1 in new business league tables in 2021 for the 3rd time in four years Industry-leading financial ratios, with operating margin rate at 17.5% and Free Cash Flow1 at €1.4bn A bonus for all employees; an exceptional one-week additional salary for the 35,000 with no variable remuneration 2022 guidance: organic growth between +4% and +5%, c. 17.5% operating margin rate and c. €1.4bn FCF1 2021 proposed dividend at €2.40 with a 47.8% payout, fully paid in cash FY 2021 Results...

Continue reading

Sampo plc’s share buybacks 02/02/2022

SAMPO PLC                 STOCK EXCHANGE RELEASE         03/02/2022 at 08:30 am Sampo plc’s share buybacks 02/02/2022 On 02/02/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  13,309 44.33 AQEU  11,776 44.33 CEUX  3,127 44.31 TQEX  41,912 44.28 XHELTOTAL 70,124 44.30  *rounded to two decimals                 On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021,...

Continue reading

Teleste: Financial statement release 2021 will be published on 10 February – invitation to press briefing

TELESTE CORPORATION         INVESTOR NEWS         3.2.2022 AT 08:30 EETTeleste will publish its Financial statement 1 January – 31 December 2021 as a stock exchange release on 10 February 2022 approx. at 08:30 a.m. EET. A briefing for analysts, media, financial institutions and professional investors will be held virtually in Teams the same day at 09:30 a.m. EET hosted by CEO, Mr. Esa Harju and CFO, Mr. Juha Hyytiäinen.PRESS BRIEFING (held in Finnish): Date: Thursday, 10 February, 2022 Time: 09:30-10:30 a.m. EET Location: Microsoft Teams meeting, link will be sent after registration Advance registration requested by noon on 9 February to: investor.relations@teleste.comHannele AhlroosTel. +358 2 2605 611Welcome! TELESTE CORPORATION Esa HarjuCEO

Continue reading

Notice regarding Absorption-type Merger of a Wholly Owned Subsidiary (Simplified merger and Short form merger)

TOKYO, Feb. 03, 2022 (GLOBE NEWSWIRE) — Internet Initiative Japan Inc. (hereinafter “IIJ”, TSE1: 3774) today announced that IIJ’s Board of Directors meeting held today resolved to carry out an absorption-type merger (hereinafter, “the Merger”) of its wholly owned subsidiary, IIJ Innovation Institution Inc. (hereinafter, “IIJ-II”), effective on April 1, 2022. Because the Merger is a simplified absorption-type merger of a wholly owned subsidiary, certain disclosure items and details are omitted. 1.    Purpose of the Merger       To further enhance business collaboration, IIJ decided to merge and absorb IIJ-II who has been engaging in research and development related to Internet with mid-to-long term perspective. 2.    Outline of the Merger (1)   Schedule of the Merger・Date of IIJ’s Board of Directors resolution February 3, 2022・Date...

Continue reading

ING Group 2021 SREP process completed

ING Group 2021 SREP process completed ING Group has been notified of the European Central Bank (ECB) decision on the 2021 Supervisory Review and Evaluation Process (SREP), based on which it has taken a decision on ING’s prudential requirements, including capital requirements for 2022. The fully loaded CET1 requirement is 10.71%, to be phased in over the next year, compared to the current 10.51%. The higher requirement is caused by the increase of the countercyclical capital buffer from 3bps to 23bps. In terms of Pillar 2 additional own funds requirement the outcome remained unchanged for ING Group following the 2021 SREP Decision, which formally supersedes the previous 2019 SREP Decision. As of 31 December 2021, ING’s fully-loaded common equity Tier 1 ratio was 15.9%, well in excess of the regulatory requirements. Further information on...

Continue reading

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francs Pharmaceuticals Division sales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilars Diagnostics Division sales grow 29%; strong momentum in base business and continued high demand for COVID-19 tests Major approvals for medicines since the last quarter: United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis) Major approvals for diagnostics since the last quarter: cobas 5800 (molecular laboratory system); Avenio Edge (sequencing sample preparation system); cobas pulse and cobas infinity edge (digital ecosystem for clinical decision...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.